A new form of gene therapy may offer a safe and effective way to treat severe combined immunodeficiency (SCID).
The U.S. Centers for Disease Control and Prevention have released a Category A recommendation for revised routine pneumococcal vaccination in older adults.
The FDA has approved Hyqvia for adult patients with primary immunodeficiency (PI).
The FDA has approved Pleximmune, a first-in-class blood test to predict acute cellular rejection of transplanted livers and intestines in children.
High uranium exposure is associated with systemic lupus erythematosus (SLE).
Newborn screening programs in the United States have identified severe combined immunodeficiency, with high survival seen in SCID-affected infants.
Review this chart on Hematological Reference Values for quick information when you need it.
With this certified-for-credit activity, review cases including "A collaborative approach to myasthenia gravis."